What ABVC Biopharma Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Stolz Kevin Patrick | VP & Controller | Jan 27 | Grant / award · A | +6,250 | — | — | 6,250 |
| Nirta Joseph | Director | May 11 | Open-market buy · P | +10,000 | $0.15 | +$1.5K | 10,000 |
| Nirta Joseph | Director | Mar 22 | Open-market buy · P | +2,000 | $0.26 | +$520 | 2,000 |
| Smith J.b. | Director | Nov 13 | Open-market buy · P | +714,286 | $50,000.00 | +$35.7B | 16,585,538 |
| Crockett Robert G | Chief Executive Officer | Sep 21 | Grant / award · A | +670,000 | $0.51 | +$342K | 1,000,000 |
| Iannotti Daniel V | VP, General Counsel & Secretar | Sep 21 | Grant / award · A | +70,000 | $0.51 | +$35.7K | 400,000 |
| Krotine Frank Thomas | President & COO | Sep 21 | Grant / award · A | +169,000 | $0.51 | +$86.2K | 510,217 |
| Smith J.b. | Director | Aug 31 | Open-market buy · P | +192,308 | $50,000.00 | +$9.62B | 18,430,752 |
| Smith J.b. | Director | Aug 19 | Gift · G | −300,000 | — | — | 17,575,000 |
| Smith J.b. | Director | Jun 10 | Open-market buy · P | +20 | $20,000.00 | +$400K | 336 |
| Smith J.b. | Director | Jun 02 | Open-market buy · P | +40 | $40,000.00 | +$1.6M | 316 |
| Smith J.b. | Director | Jun 02 | Open-market buy · P | +55 | $55,000.00 | +$3.03M | 2,436 |
| Smith J.b. | Director | Apr 29 | Open-market buy · P | +34 | $34,000.00 | +$1.16M | 2,381 |
| Smith J.b. | Director | Apr 14 | Open-market buy · P | +21 | $21,000.00 | +$441K | 2,347 |
| Smith J.b. | Director | Mar 26 | Open-market buy · P | +80 | $80,000.00 | +$6.4M | 2,326 |
| Smith J.b. | Director | Mar 10 | Open-market buy · P | +23 | $23,000.00 | +$529K | 2,246 |
| Smith J.b. | Director | Feb 26 | Open-market buy · P | +40 | $40,000.00 | +$1.6M | 2,223 |
| Smith J.b. | Director | Feb 11 | Open-market buy · P | +30 | $30,000.00 | +$900K | 2,158 |
| Smith J.b. | Director | Feb 10 | Other Transaction · J | +24 | — | — | 2,128 |
| Smith J.b. | Director | Jan 23 | Open-market buy · P | +4,000,000 | $1.00 | +$4M | 5,500,000 |
Loading...
